EMA (EU)
EVENT
Pharmacovigilance Risk Assessment Committee (PRAC): 26 - 29 October 2026
Published: 10/26/2026Detected: 10/16/2026
Summary preview
Covers the PRAC plenary session held from 26–29 October 2026, which may include updates on ongoing pharmacovigilance risk assessments, safety signal evaluations, and related regulatory actions affecting EU product…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU: Hands-on training course using the EudraVigilance system10/26/2026
- European platform for regulatory science research meeting: October 202610/22/2026
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/22/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 202610/21/2026
- 21st industry stakeholder platform - operation of European Union (EU) pharmacovigilance10/20/2026